Last $26.40 USD
Change Today +0.16 / 0.61%
Volume 115.5K
SGNT On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

sagent pharmaceuticals inc (SGNT) Snapshot

Open
$26.30
Previous Close
$26.24
Day High
$26.53
Day Low
$25.87
52 Week High
07/2/14 - $27.57
52 Week Low
02/5/14 - $17.49
Market Cap
841.2M
Average Volume 10 Days
508.4K
EPS TTM
$0.74
Shares Outstanding
31.9M
EX-Date
--
P/E TM
35.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for SAGENT PHARMACEUTICALS INC (SGNT)

Related News

No related news articles were found.

sagent pharmaceuticals inc (SGNT) Related Businessweek News

No Related Businessweek News Found

sagent pharmaceuticals inc (SGNT) Details

Sagent Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, sources, manufactures, and markets pharmaceutical products, principally injectable-based generic equivalents to branded products in the United States. The company offers anti-infective products, such as Cefepime, an antibiotic used to treat infections of the urinary tract, and skin and skin structures, as well as moderate to severe pneumonia, intra-abdominal infections, and as empiric therapy for febrile neutropenic patients; and Levofloxacin, a fluoroquinolone antibacterial for the treatment of infections caused by susceptible bacteria, including nosocomial and community acquired pneumonia, sinusitis, chronic bronchitis, skin and skin structure infections, prostatitis, urinary tract infection, and pyelonephritis in adults of age 18 years or older. It also provides oncology products consisting of Docetaxel, an antineoplastic agent used to treat advanced or metastatic breast cancer after chemotherapy failure; Leucovorin Calcium, a folic acid derivative used to prevent harmful effects of methotrexate when methotrexate is used to treat certain types of cancer; and Zoledronic Acid, a bisphosphonate given intravenously to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer, as well as for treating osteoporosis. In addition, the company offers critical care products comprising Heparin, an anticoagulant used to prevent and treat blood clotting during and after surgery and dialysis. As of December 31, 2013, its product portfolio included 53 marketed products. It sells its products to hospitals, integrated delivery networks, and alternative site facilities through pharmaceutical wholesalers and specialty distributors. The company was formerly known as Sagent Holding Co. and changed its name to Sagent Pharmaceuticals, Inc. in April 2011. Sagent Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Schaumburg, Illinois.

269 Employees
Last Reported Date: 03/7/14
Founded in 2006

sagent pharmaceuticals inc (SGNT) Top Compensated Officers

Founder, Chairman and Chief Executive Officer
Total Annual Compensation: $615.2K
President
Total Annual Compensation: $308.7K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $330.8K
Chief Legal Officer, Executive Vice President...
Total Annual Compensation: $312.7K
Executive Vice President of National Accounts...
Total Annual Compensation: $287.4K
Compensation as of Fiscal Year 2013.

sagent pharmaceuticals inc (SGNT) Key Developments

Sagent Pharmaceuticals, Inc.(NasdaqGS:SGNT) added to S&P 1000 Index

Sagent Pharmaceuticals, Inc.(NasdaqGS:SGNT) added to S&P 1000 Index

Sagent Pharmaceuticals, Inc.(NasdaqGS:SGNT) added to S&P SmallCap 600 Index

Sagent Pharmaceuticals, Inc.(NasdaqGS:SGNT) added to S&P SmallCap 600 Index

Sagent Pharmaceuticals, Inc.(NasdaqGS:SGNT) added to S&P SmallCap 600 Sector Indices – Health Care Sector Index

Sagent Pharmaceuticals, Inc.(NasdaqGS:SGNT) added to S&P SmallCap 600 Sector Indices – Health Care Sector Index

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SGNT:US $26.40 USD +0.16

SGNT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Akorn Inc $34.63 USD +0.51
Dr Reddy's Laboratories Ltd 2,695 INR -5.70
Endo International PLC $65.74 USD -0.56
Hospira Inc $50.82 USD -0.24
Pfizer Ltd/India 1,339 INR -19.15
View Industry Companies
 

Industry Analysis

SGNT

Industry Average

Valuation SGNT Industry Range
Price/Earnings 32.8x
Price/Sales 3.3x
Price/Book 3.5x
Price/Cash Flow 33.8x
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAGENT PHARMACEUTICALS INC, please visit www.sagentpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.